CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-26 | KIES PETER CFO | Grant or award · Common Stock Option | +104,833 | 104,833 | ||
| 2021-02-26 | KIES PETER CFO | Grant or award · Restricted Stock Unit | +67,633 | 67,633 | ||
| 2021-02-26 | Kim Jong Joseph Chief Executive Officer | Grant or award · Common Stock Option | +319,800 | 319,800 | ||
| 2021-02-26 | Kim Jong Joseph Chief Executive Officer | Grant or award · Restricted Stock Unit | +206,300 | 206,300 | ||
| 2021-02-26 | Humeau Laurent Chief Scientific Officer | Grant or award · Common Stock Option | +104,833 | 104,833 | ||
| 2021-02-26 | Humeau Laurent Chief Scientific Officer | Grant or award · Restricted Stock Unit | +67,633 | 67,633 | ||
| 2021-02-26 | Shea Jacqueline Elizabeth Chief Operating Officer | Grant or award · Common Stock Option | +104,833 | 104,833 | ||
| 2021-02-26 | Shea Jacqueline Elizabeth Chief Operating Officer | Grant or award · Restricted Stock Unit | +67,633 | 67,633 | ||
| 2021-02-16 | BENITO SIMON X Director | Option exercise | +2,000 | $3.56 | $7K | 53,650 |
| 2021-02-16 | BENITO SIMON X Director | Sale | −2,000 | $14.68 | $29K | 51,650 |
| 2021-02-16 | BENITO SIMON X Director | Option exercise · Common Stock Options | −2,000 | 4,000 | ||
| 2021-02-03 | Kim Jong Joseph Chief Executive Officer | Option exercise | +62,500 | $4.56 | $285K | 1,140,813 |
| 2021-02-03 | Kim Jong Joseph Chief Executive Officer | Sale | −62,500 | $14.24 | $890K | 1,078,313 |
| 2021-02-03 | Kim Jong Joseph Chief Executive Officer | Option exercise · Common Stock Option | −62,500 | 0 | ||
| 2021-02-01 | Kim Jong Joseph Chief Executive Officer | Sale | −100,000 | $15.00 | $1.5M | 1,078,313 |
| 2021-02-01 | Shea Jacqueline Elizabeth Chief Operating Officer | Option exercise | +22,376 | $3.62 | $81K | 66,871 |
| 2021-02-01 | Shea Jacqueline Elizabeth Chief Operating Officer | Sale | −22,376 | $15.06 | $337K | 44,495 |
| 2021-02-01 | Shea Jacqueline Elizabeth Chief Operating Officer | Sale | −5,960 | $15.00 | $89K | 38,535 |
| 2021-02-01 | Shea Jacqueline Elizabeth Chief Operating Officer | Option exercise · Common Stock Option | −22,376 | 100,000 | ||
| 2021-01-28 | Shea Jacqueline Elizabeth Chief Operating Officer | Option exercise | +55,248 | $3.62 | $200K | 61,208 |
Page 27 of 32 · 622 trades